Cover Image
Market Research Report

Global Polymerase Chain Reaction Market Forecast 2019-2027

Published by Inkwood Research Product code 837254
Published Content info 120 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Polymerase Chain Reaction Market Forecast 2019-2027
Published: May 13, 2019 Content info: 120 Pages
Description

KEY FINDINGS

Global polymerase chain reaction market refers to the method that produces abundant copies of a target DNA region in vitro. This chain reaction depends on a thermostable DNA polymerase called TAQ polymerase, which is extracted from Thermus aquaticus and as the name suggests, they live in hot springs and hydrothermal vents.

Global polymerase chain reaction market generated a revenue of $XX billion in 2018 & is projected to reach $13,644 million by 2027, at a CAGR of 6.19% during the forecasting years of 2019-2027. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027.

MARKET INSIGHTS

Global polymerase chain reaction market is primarily driven by increasing prevalence of infectious diseases and the growing geriatric population. The increasing investments by the key players coupled with rapid changes in technology are the prime factors which are fueling the growth of the market.

With the growing acceptance of polymerase chain reaction techniques, the global market is also facing some challenges. The inability of the conventional PCR technique to target complex endpoint sequences is limiting the growth of the PCR in the forecast period. The availability of alternative technologies for DNA sequencing is also probing as a challenge to the market in the coming years. Moreover, the high cost of instruments and the high cost of labor is further obstructing the growth of the global market.

Also, the increasing collaborations and mergers between key players for launching innovative products with more efficient polymerase chain reaction techniques will further fuel the market growth in the future.

REGIONAL INSIGHTS

Report scope of the global polymerase chain reaction market covers segmentation by several regions, namely, North America, Asia Pacific, Europe and the remaining countries collectively forming the Rest of World regional segment.

The North America polymerase chain reaction market is rising rapidly owing to the rising occurrence rate of infectious and chronic diseases such as the likes of HIV/AIDS, hepatitis, and cancer in concurrence with an increasing number of R&D activities by biotechnological & pharmaceutical companies in the region. The increasing laboratory usage for PCR in the region coupled with new product developments in the region is boosting the growth of the North America polymerase chain reaction market.

COMPETITIVE INSIGHTS

Becton Dickinson Biosciences Systems and Reagents Inc., Abbott Laboratories, Qiagen N.V., Biomerieux SA, Fluidigm Corporation, Danaher Corporation, Siemens Healthineers, MDXhealth Corporation, Agilent Technologies Inc., Pacific Biosciences of California, Inc., Nano Biosys Inc., Bio-Rad Technologies Inc., Tahara Bio Inc., Thermo Fisher Scientific Inc., and F. Hoffman La Roche Ltd. are the major companies operating in the market which have been thoroughly outlined in the report.

Table of Contents
Product Code: 24950

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REAGENTS AND CONSUMABLES HOLDS THE LARGEST MARKET SHARE
    • 3.2.2. RISE IN INFECTIOUS DISEASES WORLDWIDE
    • 3.2.3. INCREASING DEMAND FOR DIGITAL PCR

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISING INCIDENCES OF INFECTIONS AND DISEASES
    • 4.2.2. DEVELOPMENT IN PHARMACOGENOMICS
    • 4.2.3. EMERGENCE OF DIGITAL PCR
    • 4.2.4. INCREASING PUBLIC-PRIVATE INVESTMENTS AND GRANTS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. NON-VALIDATED HOME BREW TESTS
    • 4.3.2. HIGH DEVICE COSTS ASSOCIATED WITH PCR
    • 4.3.3. NECESSITY OF TRAINING AND UPDATION OF LABORATORIES WORKERS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. RISE IN FUNDING OF GENE AND HUMAN GENOME PROJECTS
    • 4.4.2. EXPANDING HEALTHCARE MARKET IN APAC
  • 4.5. MARKET CHALLENGES
    • 4.5.1. INACCURACY CAUSED BY THE PCR TECHNIQUES
    • 4.5.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES

5. MARKET BY TECHNOLOGY

  • 5.1. REAL-TIME PCR
  • 5.2. TRADITIONAL PCR
  • 5.3. DIGITAL PCR

6. MARKET BY PRODUCT

  • 6.1. REAGENT AND CONSUMABLES
  • 6.2. INSTRUMENTS
  • 6.3. SOFTWARE
  • 6.4. SERVICES

7. MARKET BY APPLICATION

  • 7.1. CLINICAL
  • 7.2. RESEARCH
  • 7.3. FORENSICS

8. MARKET BY END-USER

  • 8.1. DIAGNOSTIC CENTERS & HOSPITALS
  • 8.2. BIOTECH & PHARMA COMPANIES
  • 8.3. ACADEMIC AND RESEARCH INSTITUTES

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCE MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF SUPPLIERS
    • 9.1.4. BARGAINING POWER OF BUYERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. OPPORTUNITY MATRIX
  • 9.3. VENDOR LANDSCAPE

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. UNITED STATES
    • 10.1.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. UNITED KINGDOM
    • 10.2.2. GERMANY
    • 10.2.3. FRANCE
    • 10.2.4. SPAIN
    • 10.2.5. ITALY
    • 10.2.6. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. CHINA
    • 10.3.2. JAPAN
    • 10.3.3. INDIA
    • 10.3.4. SOUTH KOREA
    • 10.3.5. AUSTRALIA
    • 10.3.6. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. LATIN AMERICA
    • 10.4.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. COMPANY PROFILES
    • 11.1.1. AGILENT TECHNOLOGIES INC.
    • 11.1.2. BIORAD TECHNOLOGIES INC.
    • 11.1.3. QIAGEN N.V.
    • 11.1.4. F. HOFFMAN LA ROCHE LTD.
    • 11.1.5. THERMOFISHER SCIENTIFIC INC.
    • 11.1.6. ABBOTT LABORATORIES
    • 11.1.7. BECTON DICKINSON BIOSCIENCES SYSTEMS AND REAGENTS INC.
    • 11.1.8. SIEMENS HEALTHINEERS
    • 11.1.9. BIOMERIEUX SA
    • 11.1.10. DANAHER CORPORATION
    • 11.1.11. MDXHEALTH CORPORATION
    • 11.1.12. NANO BIOSYS INC.
    • 11.1.13. TAHARA BIO INC.
    • 11.1.14. FLUIDIGM CORPORATION
    • 11.1.15. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

LIST OF TABLES

  • TABLE 1. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
  • TABLE 2. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)
  • TABLE 3. GLOBAL PCR MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)
  • TABLE 4. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)
  • TABLE 5. GLOBAL REAGENT AND CONSUMABLES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 7. GLOBAL SOFTWARE MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 8. GLOBAL SERVICES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 9. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY APPLICATION, 2019-2027, (IN $ MILLION)
  • TABLE 10. GLOBAL CLINICAL MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 11. GLOBAL RESEARCH MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 12. GLOBAL FORENSICS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 13. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY END USER 2019-2027, (IN $ MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC CENTERS & HOSPITALS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 15. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 16. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 17. OPPORTUNITY MATRIX
  • TABLE 18. VENDOR LANDSCAPE
  • TABLE 19. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)
  • TABLE 20. NORTH AMERICA POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 21. EUROPE POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 22. ASIA PACIFIC POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 23. REST OF WORLD POLYMERASE CHAIN (PCR) MARKET, BY REGION, 2019-2027 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TYPE, 2018 & 2027 (IN %)
  • FIGURE 2. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)
  • FIGURE 3. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TRADITIONAL PCR, 2019-2027 (IN $ MILLION)
  • FIGURE 4. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 (IN $ MILLION)
  • FIGURE 5. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
  • FIGURE 6. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY SOFTWARE, 2019-2027 (IN $ MILLION)
  • FIGURE 7. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY SERVICES, 2019-2027 (IN $ MILLION)
  • FIGURE 8. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY CLINICAL, 2019-2027 (IN $ MILLION)
  • FIGURE 9. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY RESEARCH, 2019-2027 (IN $ MILLION)
  • FIGURE 10. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY FORENSICS, 2019-2027 (IN $ MILLION)
  • FIGURE 11. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY DIAGNOSTIC CENTERS & HOSPITALS, 2019-2027 (IN $ MILLION)
  • FIGURE 12. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY BIOTECH & PHARMA COMPANIES, 2019-2027 (IN $ MILLION)
  • FIGURE 13. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
  • FIGURE 14. PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 15. GLOBAL POLYMERASE CHAIN (PCR) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 16. UNITED STATES POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 17. CANADA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 18. UNITED KINGDOM POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 19. GERMANY POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 20. FRANCE POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 21. SPAIN POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 22. ITALY POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 23. REST OF EUROPE POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 24. CHINA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 25. JAPAN POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 26. INDIA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 27. SOUTH KOREA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 28. AUSTRALIA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 29. REST OF ASIA PACIFIC POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 30. LATIN AMERICA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 31. MIDDLE EAST & AFRICA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
Back to Top